Review article · 2025 · Open access

Fragment-to-Lead Medicinal Chemistry Publications in 2024: A Tenth Annual Perspective

David G. Twigg, Kenta Arai, Michelle R. Arkin, Daniel A. Erlanson, Iwan J. P. de Esch, Barbara Farkaš, Stephen W. Fesik, Wolfgang Jahnke, Christopher N. Johnson, Martin Schroeder

Journal of Medicinal Chemistry, 68(23), 24830–24847 · Published 25 November 2025 · DOI 10.1021/acs.jmedchem.5c02894

Open full textView at the publisherCite this paper

In brief

“Fragment-to-Lead Medicinal Chemistry Publications in 2024: A Tenth Annual Perspective” is a 2025 review article by David G. Twigg and 9 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 23 citations as of 17 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access: the full text is free to read at VU Research Portal.

Citations
23
Most cited in
2026 (23)
Field-weighted impact
1.15
References
110
Authors
10

Abstract

Fragment-based drug discovery (FBDD) has led to dozens of clinical compounds, including eight approved drugs. For the past decade, we have published an annual review of successful fragment-to-lead (F2L) medicinal chemistry programs. This Perspective marks the tenth in the series. We analyze the 18 F2L case studies from 2024 and put them in the context of the larger set of 233 examples dating back to 2015. We hope that the lessons herein will both inform and inspire researchers to discover the next generation of drugs.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Twigg, D. G., Arai, K., Arkin, M. R., Erlanson, D. A., de Esch, I. J. P., Farkaš, B., Fesik, S. W., Jahnke, W., Johnson, C. N., & Schroeder, M. (2025). Fragment-to-Lead Medicinal Chemistry Publications in 2024: A Tenth Annual Perspective. Journal of Medicinal Chemistry, 68(23), 24830–24847. https://doi.org/10.1021/acs.jmedchem.5c02894

MLA 9

Twigg, David G., et al. “Fragment-to-Lead Medicinal Chemistry Publications in 2024: A Tenth Annual Perspective.” Journal of Medicinal Chemistry, vol. 68, no. 23, 2025, pp. 24830–24847. https://doi.org/10.1021/acs.jmedchem.5c02894.

Chicago

Twigg, David G., Kenta Arai, Michelle R. Arkin, Daniel A. Erlanson, Iwan J. P. de Esch, Barbara Farkaš, Stephen W. Fesik, Wolfgang Jahnke, Christopher N. Johnson, and Martin Schroeder. 2025. “Fragment-to-Lead Medicinal Chemistry Publications in 2024: A Tenth Annual Perspective.” Journal of Medicinal Chemistry 68 (23): 24830–24847. https://doi.org/10.1021/acs.jmedchem.5c02894.

Harvard

Twigg, D. G. et al. (2025) ‘Fragment-to-Lead Medicinal Chemistry Publications in 2024: A Tenth Annual Perspective’, Journal of Medicinal Chemistry, 68(23), pp. 24830–24847. doi:10.1021/acs.jmedchem.5c02894.

IEEE

D. G. Twigg et al., “Fragment-to-Lead Medicinal Chemistry Publications in 2024: A Tenth Annual Perspective,” Journal of Medicinal Chemistry, vol. 68, no. 23, pp. 24830–24847, 2025, doi: 10.1021/acs.jmedchem.5c02894.

BibTeX

@article{twigg2025fragment,
  title     = {{Fragment-to-Lead Medicinal Chemistry Publications in 2024: A Tenth Annual Perspective}},
  author    = {Twigg, David G. and Arai, Kenta and Arkin, Michelle R. and Erlanson, Daniel A. and de Esch, Iwan J. P. and Farkaš, Barbara and Fesik, Stephen W. and Jahnke, Wolfgang and Johnson, Christopher N. and Schroeder, Martin},
  journal   = {Journal of Medicinal Chemistry},
  year      = {2025},
  volume    = {68},
  number    = {23},
  pages     = {24830--24847},
  doi       = {10.1021/acs.jmedchem.5c02894},
  url       = {https://doi.org/10.1021/acs.jmedchem.5c02894}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • fragment-based drug discovery
  • medicinal chemistry
  • hit-to-lead optimization

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Twigg, D. G., Arai, K., Arkin, M. R., Erlanson, D. A., de Esch, I. J. P., Farkaš, B., Fesik, S. W., Jahnke, W., Johnson, C. N., & Schroeder, M. (2025). Fragment-to-Lead Medicinal Chemistry Publications in 2024: A Tenth Annual Perspective. Journal of Medicinal Chemistry, 68(23), 24830–24847. https://doi.org/10.1021/acs.jmedchem.5c02894

How many times has this paper been cited?

23 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at VU Research Portal: sign in and open the full text from this page.

Who wrote this paper?

David G. Twigg, Kenta Arai, Michelle R. Arkin, Daniel A. Erlanson, Iwan J. P. de Esch, Barbara Farkaš, Stephen W. Fesik, Wolfgang Jahnke, Christopher N. Johnson, Martin Schroeder.

What is the DOI of this paper?

10.1021/acs.jmedchem.5c02894, permanently at https://doi.org/10.1021/acs.jmedchem.5c02894. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.